Screener
Kura Oncology KURA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
Based on the most recent quarter.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's current ratio?
- Kura Oncology (KURA) reported current ratio of 6.1× in Q1 2026.
- How has Kura Oncology's current ratio changed year-over-year?
- Kura Oncology's current ratio decreased by 23.8% year-over-year, from 8.1× to 6.1×.
- What is the long-term trend for Kura Oncology's current ratio?
- Over 5 years (2020 to 2025), Kura Oncology's current ratio has grown at a -24.4% compound annual growth rate (CAGR), from 24.5× to 6.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Kura Oncology's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude